Ruth Melody Hornady, APRN, AGACNP Registered Nurse - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 N, Tx-118, Alpine, TX 79830 Phone: 432-837-3447 |
Lovette Robinson, NP Registered Nurse - Medical-Surgical Medicare: Accepting Medicare Assignments Practice Location: 2600 N Tx-118, Alpine, TX 79830 Phone: 432-837-3447 |
News Archive
A new analysis of the California Teachers Study, which analyzed hormone replacement therapy use among 2,857 women for almost 10 years, underscores the need for personalized risk-benefit discussions before women begin hormone therapy."This is evidence that the story is complicated," said Tanmai Saxena, an M.D./Ph.D. student at the Keck School of Medicine at the University of Southern California. "The benefits of hormone therapy for relief of postmenopausal symptoms among women are clear, but the risks are more complicated than we had previously thought."
Concerns about the use of letrozole, an easy-to-use and inexpensive drug for the treatment of infertility, appear to be unfounded, according to a major study co-authored by Dr. Togas Tulandi, Director of Division of Reproductive Endocrinology and Infertility, McGill University Health Centre (MUHC) and Chief of Obstetrics and Gynecology at the Jewish General Hospital, and Professor of Obstetrics and Gynecology at McGill University.
Among about 100,000 study participants, screening with flexible sigmoidoscopy resulted in a reduced incidence and rate of death of colorectal cancer, compared to no screening, according to a study in the August 13 issue of JAMA.
Choosing dairy milk may make a difference when it comes to your child's growth, according to a new study from the American Journal of Clinical Nutrition. Researchers found drinking non-dairy alternatives was associated with shorter childhood height compared to those who drank milk, among 5,000 Canadian children.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).
› Verified 2 days ago